Objective: To investigate the relative bioavailability and bioequivalence, in fasting and fed conditions, of repeated doses of two omeprazole enteric-coated formulations in healthy volunteers.

Objectives were to provide dose-increment justification for conversion of a patient from conventional enteric-coated divalproex to a once-daily divalproex ER regimen and to discuss the ...

The Criminal Investigation and Detection Group (CIDG) have arrested two Chinese nationals allegedly involved in selling unregistered medicines in Metro Manila. Agents of the CIDG-Detective and Special ...

SaSPinjara Life Sciences sees Indian pharma boosting capability in high-demand therapeutics: Nandita Vijayasimha, Bengaluru Saturday, February 1, 2025, 08:00 Hrs [IST] SaSPinjara ...

According to DelveInsight’s epidemiology model, the total diagnosed prevalent cases of Parkinson’s disease were approximately ...

Life Sciences announced it was issued a new U.S. Patent No. 12,180,174 entitled “A2-73 CRYSTALLINE POLYMORPH COMPOSITIONS OF ...

Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company focused on developing innovative treatments for Alzheimer's disease, Parkinson's ...

Valentine’s Day is often about expressing love through grand gestures, but lasting care goes beyond a single day. More than ...

Learn more about norovirus, how to prevent contracting it, and why this year has seen such a surge in cases.